BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8509378)

  • 1. Mg2+ inhibits formation of 4Ca(2+)-calmodulin-enzyme complex at lower Ca2+ concentration. 1H and 113Cd NMR studies.
    Ohki S; Iwamoto U; Aimoto S; Yazawa M; Hikichi K
    J Biol Chem; 1993 Jun; 268(17):12388-92. PubMed ID: 8509378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication between two globular domains of calmodulin in the presence of mastoparan or caldesmon fragment. Ca2+ binding and 1H NMR.
    Yazawa M; Ikura M; Hikichi K; Ying L; Yagi K
    J Biol Chem; 1987 Aug; 262(23):10951-4. PubMed ID: 3611098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 113Cd-NMR evidence for cooperative interaction between amino- and carboxyl-terminal domains of calmodulin.
    Ikura M; Hasegawa N; Aimoto S; Yazawa M; Yagi K; Hikichi K
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1233-8. PubMed ID: 2742586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastoparan binding induces Ca(2+)-transfer between two globular domains of calmodulin: a 1H NMR study.
    Ohki SY; Yazawa M; Yagi K; Hikichi K
    J Biochem; 1991 Nov; 110(5):737-42. PubMed ID: 1783604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastoparan binding induces a structural change affecting both the N-terminal and C-terminal domains of calmodulin. A 113Cd-NMR study.
    Linse S; Drakenberg T; Forsén S
    FEBS Lett; 1986 Apr; 199(1):28-32. PubMed ID: 3956744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal ion and drug binding to proteolytic fragments of calmodulin: proteolytic, cadmium-113, and proton nuclear magnetic resonance studies.
    Thulin E; Andersson A; Drakenberg T; Forsén S; Vogel HJ
    Biochemistry; 1984 Apr; 23(8):1862-70. PubMed ID: 6722127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H NMR studies of mastoparan binding by calmodulin.
    Muchmore DC; Malencik DA; Anderson SR
    Biochem Biophys Res Commun; 1986 Jun; 137(3):1069-78. PubMed ID: 3729951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the binding of magnesium (II) to calmodulin significant? An investigation by magnesium-25 nuclear magnetic resonance.
    Tsai MD; Drakenberg T; Thulin E; Forsén S
    Biochemistry; 1987 Jun; 26(12):3635-43. PubMed ID: 3651401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optical method for evaluating ion selectivity for calcium signaling pathways in the cell.
    Ozawa T; Kakuta M; Sugawara M; Umezawa Y; Ikura M
    Anal Chem; 1997 Aug; 69(15):3081-5. PubMed ID: 9253254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Ca2+ binding sites of calmodulin from bovine testis using 43Ca and 113Cd NMR.
    Andersson T; Drakenberg T; Forsén S; Thulin E
    Eur J Biochem; 1982 Sep; 126(3):501-5. PubMed ID: 7140742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium binding and conformational properties of calmodulin complexed with peptides derived from myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP).
    Porumb T; Crivici A; Blackshear PJ; Ikura M
    Eur Biophys J; 1997; 25(4):239-47. PubMed ID: 9112755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H NMR study on amide proton exchange of calmodulin-mastoparan complex.
    Ohki S; Tsuda S; Joko S; Yazawa M; Yagi K; Hikichi K
    J Biochem; 1991 Feb; 109(2):234-7. PubMed ID: 1864836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin and troponin C: affinity chromatographic study of divalent cation requirements for troponin I inhibitory peptide (residues 104-115), mastoparan and fluphenazine binding.
    Van Eyk JE; Hodges RS
    Biochem Cell Biol; 1987 Nov; 65(11):982-8. PubMed ID: 3442631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal ion binding to calmodulin: NMR and fluorescence studies.
    Ouyang H; Vogel HJ
    Biometals; 1998 Sep; 11(3):213-22. PubMed ID: 9850564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement by Mg2+ of domain specificity in Ca2+-dependent interactions of calmodulin with target sequences.
    Martin SR; Masino L; Bayley PM
    Protein Sci; 2000 Dec; 9(12):2477-88. PubMed ID: 11206069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump.
    Elshorst B; Hennig M; Försterling H; Diener A; Maurer M; Schulte P; Schwalbe H; Griesinger C; Krebs J; Schmid H; Vorherr T; Carafoli E
    Biochemistry; 1999 Sep; 38(38):12320-32. PubMed ID: 10493800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermolecular tuning of calmodulin by target peptides and proteins: differential effects on Ca2+ binding and implications for kinase activation.
    Peersen OB; Madsen TS; Falke JJ
    Protein Sci; 1997 Apr; 6(4):794-807. PubMed ID: 9098889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of myristoylated N-terminal nonapeptide from neuro-specific protein CAP-23/NAP-22 to calmodulin does not induce the globular structure observed for the calmodulin-nonmyristylated peptide complex.
    Hayashi N; Izumi Y; Titani K; Matsushima N
    Protein Sci; 2000 Oct; 9(10):1905-13. PubMed ID: 11106163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.